Company intelligence / Profile preview

DNA Diagnostic

Ownership: Private
Development stage: Commercial

Overview

DNA Diagnostic A/S develops fast and reliable PCR/qPCR-based diagnostic test kits primarily for leukemia screening via chromosome translocation detection, food safety pathogen screening including Salmonella and Listeria species, veterinary pathogen detection, and milk quality control. Their HemaVision product line is CE IVD marked for clinical use in leukemia diagnostics. They also have certified products like Salmonella Velox that are NordVal certified.

Therapeutic areas: OtherOncologyInfectious Diseases
Modalities: PCR test kitsqPCR test kits
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on DNA Diagnostic.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA Diagnostic.

Explore the full profile